Skip to main content

Table 1 Patient and tumor characteristics for patients with limited stage small cell lung cancer (LS-SCLC) treated with chemoradiation, (n = 105)

From: The impact of quantitative CT-based tumor volumetric features on the outcomes of patients with limited stage small cell lung cancer

Characteristic

N = 105 (%)

Gender

 Female

42 (40%)

 Male

63 (60%)

Age

 Median (range)

63.8 (range 44.4–87.5)

 ≥60

71 (68%)

 < 60

34 (32%)

Race

 White

93 (89%)

 African American

6 (6%)

 Asian

1 (1%)

 Not available/other

5 (5%)

Performance score

 0

32 (30%)

 1

53 (51%)

 2

15 (14%)

 3

4 (4%)

 Unknown

1 (1%)

Smoking History

 Current smoker at time of dx of < 1 year prior

56 (53%)

 Former smoker (quit > 1 year prior)

46 (44%)

 Never smoker

3 (3%)

Pack-years

 Median (range)

45 (1.3–127.5)

T stage

 T0

3 (3%)

 T1

28 (27%)

 T2

12 (11%)

 T3

27 (26%)

 T4

35 (33%)

N stage

 N0

6 (6%)

 N1

11 (10%)

 N2

55 (52%)

 N3

33 (31%)

Overall stage

 IA1

1 (1%)

 IA3

2 (2%)

 IIB

6 (6%)

 IIIA

33 (31%)

 IIIB

41 (39%)

 IIIC

22 (21%)

Tumor volume (cm3)

 Median (range)

48.5 (0.2–428)

Maximum 2D tumor diameter axial (cm)

 Median (range)

7.4 (1.0–15.1)

Maximum 2D tumor diameter coronal (cm)

 Median (range)

8.6 (0.6–21.6)

Maximum 2D tumor diameter sagittal (cm)

 Median (range)

8.30 (0.9–20.7)

Maximum 3D tumor diameter (cm)

 Median (range)

10.8 (1.0–22.2)